Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
The surgical management for recurrent endolymphatic stromal myosis metastatic to the inferior vena cava is described. Positive estrogen and progesterone receptors in the resected tumor are reported. A plan of therapy is suggested for patients with endolymphatic stromal myosis, including a rationale for adjuvant progestin therapy.
Montag
T W
TW
Department of Obstetrics and Gynecology, Saint Joseph Hospital, Denver, Colorado 80205.
Manart
F D
FD
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009360:Neoplastic Cells, Circulating; D010386:Pelvic Neoplasms / Q000032:analysis / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012082:Renal Veins / Q000473:pathology; D012509:Sarcoma / Q000032:analysis / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D014682:Vena Cava, Inferior / Q000473:pathology
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004966:Estrogens, Conjugated (USP); D006728:Hormones; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone